000 | 01954 a2200493 4500 | ||
---|---|---|---|
005 | 20250513104312.0 | ||
264 | 0 | _c19961230 | |
008 | 199612s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.93.23.13304 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSalin, P A | |
245 | 0 | 0 |
_aDistinct short-term plasticity at two excitatory synapses in the hippocampus. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cNov 1996 |
||
300 |
_a13304-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_a4-Aminopyridine _xpharmacology |
650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xpharmacology |
650 | 0 | 4 | _aCalcium-Calmodulin-Dependent Protein Kinase Type 2 |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 |
_aEgtazic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aEvoked Potentials _xdrug effects |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHippocampus _xphysiology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aLong-Term Potentiation |
650 | 0 | 4 |
_aMagnesium _xpharmacology |
650 | 0 | 4 |
_aNerve Fibers _xdrug effects |
650 | 0 | 4 | _aNeuronal Plasticity |
650 | 0 | 4 |
_aNeurons _xphysiology |
650 | 0 | 4 |
_aPyramidal Cells _xphysiology |
650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
650 | 0 | 4 |
_aReceptors, AMPA _xdrug effects |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xdrug effects |
650 | 0 | 4 |
_aSynapses _xphysiology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aScanziani, M | |
700 | 1 | _aMalenka, R C | |
700 | 1 | _aNicoll, R A | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 93 _gno. 23 _gp. 13304-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.93.23.13304 _zAvailable from publisher's website |
999 |
_c8910053 _d8910053 |